Researchers from The University of Manchester and The University of Nottingham evaluated the cost-effectiveness of a TPMT genotyping test to inform azathioprine prescribing in autoimmune diseases. They calculated the incremental costs and quality-adjusted-life-years QALYs associated with the test by conducting an economic evaluation alongside a pragmatic randomized controlled trial in the North West of England.
Press release from ISPOR
University of NottinghamUniversity Park Nottingham, NG7 2RD
For all enquiries please visit: www.nottingham.ac.uk/enquiry